Cargando…

Systematic Review of Treatment for Trapped Thrombus in Patent Foramen Ovale

BACKGROUND AND OBJECTIVES: Trapped thrombus in patent foramen ovale (PFO) is a rare complication of pulmonary embolism that may lead to tragic clinical events. The aim of this study was to identify the optimal treatment for different clinical situations in patients with trapped thrombus in a PFO by...

Descripción completa

Detalles Bibliográficos
Autores principales: Seo, Won-Woo, Kim, Sung Eun, Park, Myung-Soo, Lee, Jun-Hee, Park, Dae-Gyun, Han, Kyoo-Rok, Oh, Dong-Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Cardiology 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614954/
https://www.ncbi.nlm.nih.gov/pubmed/28955396
http://dx.doi.org/10.4070/kcj.2016.0295
_version_ 1783266484562165760
author Seo, Won-Woo
Kim, Sung Eun
Park, Myung-Soo
Lee, Jun-Hee
Park, Dae-Gyun
Han, Kyoo-Rok
Oh, Dong-Jin
author_facet Seo, Won-Woo
Kim, Sung Eun
Park, Myung-Soo
Lee, Jun-Hee
Park, Dae-Gyun
Han, Kyoo-Rok
Oh, Dong-Jin
author_sort Seo, Won-Woo
collection PubMed
description BACKGROUND AND OBJECTIVES: Trapped thrombus in patent foramen ovale (PFO) is a rare complication of pulmonary embolism that may lead to tragic clinical events. The aim of this study was to identify the optimal treatment for different clinical situations in patients with trapped thrombus in a PFO by conducting a literature review. SUBJECTS AND METHODS: A PubMed database search was conducted from 1991 through 2015, and 194 patients (185 articles) with trapped thrombus in a PFO were identified. Patient characteristics, paradoxical embolic events, and factors affecting 60-day mortality were analyzed retrospectively. RESULTS: Among all patients, 112 (57.7%) were treated with surgery, 28 with thrombolysis, and 54 with anticoagulation alone. Dyspnea (79.4%), chest pain (33.0%), and syncope (17.5%) were the most common presenting symptoms. Pretreatment embolism was found in 37.6% of cases, and stroke (24.7%) was the most common event. Surgery was associated with fewer post-treatment embolic events than were other treatment options (p=0.044). In the multivariate analysis, initial shock or arrest, and thrombolysis were independent predictors of 60-day mortality. Thrombolysis was related with higher 60-day mortality compared with surgery in patients who had no initial shock or arrest. CONCLUSION: This systematic review showed that surgery was associated with a lower overall incidence of post-treatment embolic events and a lower 60-day mortality in patients with trapped thrombus in a PFO. In patients without initial shock or arrest, thrombolysis was related with a higher 60-day mortality compared with surgery.
format Online
Article
Text
id pubmed-5614954
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher The Korean Society of Cardiology
record_format MEDLINE/PubMed
spelling pubmed-56149542017-09-27 Systematic Review of Treatment for Trapped Thrombus in Patent Foramen Ovale Seo, Won-Woo Kim, Sung Eun Park, Myung-Soo Lee, Jun-Hee Park, Dae-Gyun Han, Kyoo-Rok Oh, Dong-Jin Korean Circ J Original Article BACKGROUND AND OBJECTIVES: Trapped thrombus in patent foramen ovale (PFO) is a rare complication of pulmonary embolism that may lead to tragic clinical events. The aim of this study was to identify the optimal treatment for different clinical situations in patients with trapped thrombus in a PFO by conducting a literature review. SUBJECTS AND METHODS: A PubMed database search was conducted from 1991 through 2015, and 194 patients (185 articles) with trapped thrombus in a PFO were identified. Patient characteristics, paradoxical embolic events, and factors affecting 60-day mortality were analyzed retrospectively. RESULTS: Among all patients, 112 (57.7%) were treated with surgery, 28 with thrombolysis, and 54 with anticoagulation alone. Dyspnea (79.4%), chest pain (33.0%), and syncope (17.5%) were the most common presenting symptoms. Pretreatment embolism was found in 37.6% of cases, and stroke (24.7%) was the most common event. Surgery was associated with fewer post-treatment embolic events than were other treatment options (p=0.044). In the multivariate analysis, initial shock or arrest, and thrombolysis were independent predictors of 60-day mortality. Thrombolysis was related with higher 60-day mortality compared with surgery in patients who had no initial shock or arrest. CONCLUSION: This systematic review showed that surgery was associated with a lower overall incidence of post-treatment embolic events and a lower 60-day mortality in patients with trapped thrombus in a PFO. In patients without initial shock or arrest, thrombolysis was related with a higher 60-day mortality compared with surgery. The Korean Society of Cardiology 2017-09 2017-09-11 /pmc/articles/PMC5614954/ /pubmed/28955396 http://dx.doi.org/10.4070/kcj.2016.0295 Text en Copyright © 2017. The Korean Society of Cardiology https://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Seo, Won-Woo
Kim, Sung Eun
Park, Myung-Soo
Lee, Jun-Hee
Park, Dae-Gyun
Han, Kyoo-Rok
Oh, Dong-Jin
Systematic Review of Treatment for Trapped Thrombus in Patent Foramen Ovale
title Systematic Review of Treatment for Trapped Thrombus in Patent Foramen Ovale
title_full Systematic Review of Treatment for Trapped Thrombus in Patent Foramen Ovale
title_fullStr Systematic Review of Treatment for Trapped Thrombus in Patent Foramen Ovale
title_full_unstemmed Systematic Review of Treatment for Trapped Thrombus in Patent Foramen Ovale
title_short Systematic Review of Treatment for Trapped Thrombus in Patent Foramen Ovale
title_sort systematic review of treatment for trapped thrombus in patent foramen ovale
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614954/
https://www.ncbi.nlm.nih.gov/pubmed/28955396
http://dx.doi.org/10.4070/kcj.2016.0295
work_keys_str_mv AT seowonwoo systematicreviewoftreatmentfortrappedthrombusinpatentforamenovale
AT kimsungeun systematicreviewoftreatmentfortrappedthrombusinpatentforamenovale
AT parkmyungsoo systematicreviewoftreatmentfortrappedthrombusinpatentforamenovale
AT leejunhee systematicreviewoftreatmentfortrappedthrombusinpatentforamenovale
AT parkdaegyun systematicreviewoftreatmentfortrappedthrombusinpatentforamenovale
AT hankyoorok systematicreviewoftreatmentfortrappedthrombusinpatentforamenovale
AT ohdongjin systematicreviewoftreatmentfortrappedthrombusinpatentforamenovale